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Leishmaniasis is a serious health problem in several parts of the world, and localized cutaneous leish-
maniasis (LCL) is the most frequent presentation of the tegumentary form of this disease cluster. Clinical
presentations of leishmaniasis are inﬂuenced by both parasite and host factors, with emphasis on the
host immune response. Alterations in plasma hormone levels have been described in many infections,
and changes in hormone levels could be related to an imbalanced cytokine proﬁle. In the present work,
we evaluated a group of patients with LCL to determine changes in plasma hormone levels (cortisol,
DHEA-S, estradiol, prolactin and testosterone) and their association with clinical markers of disease
(lesion size, dose used to reach cure and time to cure) and with cytokines produced by PBMC stimulated
by SLA (IFN-c, IL-10 and TNF-a). Individuals with LCL exhibited lower plasma levels of DHEA-S, prolactin
and testosterone compared with sex-matched controls, whereas levels of cortisol and estradiol were sim-
ilar between patients and controls. Plasma levels of cortisol, estradiol or prolactin positively correlated
with at least one clinical parameter. Cortisol and prolactin levels exhibited a negative correlation with
levels of IFN-c, whereas no correlation was observed with IL-10 or TNF-a levels. A decrease in DHEA-S
levels was observed in male LCL patients when compared to male healthy controls. No other differences
between the sexes were observed. Our results indicate a role for neuroendocrine regulation that restricts
Th1 responses in human LCL. It is possible that, although impairing parasite killing, such neuroimmuno-
modulation may contribute to limiting tissue damage.
 2011 Elsevier Inc. Open access under the Elsevier OA license. 1. Introduction
Leishmaniasis comprises a cluster of diseases caused by
different species of protozoa of the genus, Leishmania. Leishmania-
sis is endemic in many areas of the world, including Brazil, and
represents a serious public health problem (WHO, 2007). In Brazil,
localized cutaneous leishmaniasis (LCL) is caused mainly by
L. braziliensis and L. amazonensis (Grimaldi et al., 1989). Protection
is associated with the development of a T helper-1 (Th1) type
cell-mediated immune response (Alexander and Bryson, 2005).de Biofunção, Instituto de
lvador, BA 40140-100, Brazil.
n, Laboratory of Malaria and
Infectious Diseases, National
evier OA license. Neuroimmunomodulatory effects have been implicated in
leishmaniasis. Stress, gender and age can inﬂuence disease out-
come in mice and hamsters (Alexander, 1988; Travi et al., 2002;
Ruiz et al., 2003; Ehrchen et al., 2004), and hormonal changes have
been described in patients infected with L. mexicana (Gallindo-
Sevilla et al., 2007). Changes in plasma hormone levels have been
correlated with an imbalanced cytokine proﬁle in several acute
and chronic infections (Reincke et al., 1998; Bhasin et al., 2001;
Leal et al., 2003, 2006; Mavoungou et al., 2005; Libonati et al.,
2006; Del Rey et al., 2007; Gallindo-Sevilla et al., 2007; Pinto
et al., 2007). Hormone level changes have also been implicated in
the establishment of human malaria (Kurtis et al., 2001).
Stimulation of neuroendocrine axes, such as hypothalamus–
pituitary–adrenal (HPA) and hypothalamus–pituitary–gonads
(HPG) induces secretion of hormones which have profound effects
on immune response (Besedovsky et al., 1986; Webster et al.,
2002). Glucocorticoids (GC) have been recognized as important
immumodulators, promoting a shift from a Th1 to a Th2 cytokine
response (Ramírez et al., 1996; Ashwell et al., 2000). DHEA is a
Table 1
Clinical data of patients with LCL.
Males Females
Number 39 18
Age (years) 29.44 ± 15.38* 37.11 ± 24.75*
Positivity of DTH (%) 78.95 62.50
Lymphadenopathy (%) 60.00 56.20
Location of lesion (%) 59.00 lower limb 66.60 lower limb
Lesion size (cm) 3.53 ± 2.12* 2.73 ± 1.16*
Healing time (days) 78.92 ± 45.57* 68.06 ± 23.19*
Dose (mg/kg) 68.46 ± 37.08* 61.39 ± 28.54*
Number of lesions 1.54 ± 1.16* 1.50 ± 1.15*
* Mean ± standard deviation.
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effects of glucocorticoids (Hazeldine et al., 2010). Estrogens can
stimulate antibody production by B cells as well as production of
IL-4 and IL-10 (Kanda and Tamaki, 1999; Janele et al., 2006; Straub,
2007). Prolactin and testosterone also produce changes in immune
system (Ansar et al., 1985; Olsen and Kovacs, 1996; Brand et al.,
2004; Cutolo et al., 2004; Dimitrov et al., 2004).
In the present work, we studied a well-characterized group of
male and female LCL patients to investigate hormonal changes in
this infection. We also evaluated the relationship between plasma
hormone levels and both clinical markers of disease and markers of
the immune response.
2. Materials and methods
2.1. Study population
Patients included in this study (n = 57) were selected at the Cen-
tro de Referência Pirajá da Silva, Jequié (Bahia, Brazil), an endemic
area for L. braziliensis (de Oliveira et al., 2003). The clinical diagnosis
was based on the presence of lesions compatible with LCL, which
were conﬁrmed by positive intradermal reaction (DTH test) to the
Leishmania antigen and, detection of Leishmania parasites in biopsy
samples after microscopic examination of histological sections or a
positive therapeutic test, which was deﬁned as clinical cure follow-
ing treatment with Glucantime (20 mg of meglumine antimoniate
per kgper daygiven in cycles of 20 days). Datawere collectedusinga
standard protocol chart containing the following information: iden-
tiﬁcation, clinical complaints, physical examination and results of
laboratory tests. Exclusion criteriawere the following: other pathol-
ogies and infections, treatment with hormones or immunosuppres-
sants, alcoholism, pregnancy and amenorrhea. All procedures were
approved by the Ethical Committee of Hospital Universitário Edgard
Santos – UFBA, BA. Age-matched normal volunteers (NV) living in
the same endemic area (n = 32; 17 men and 15 women) served as
controls for the study. NV had no history of cutaneous lesions char-
acteristic of leishmaniasis and tested negative for the intradermal
delayed-type hypersensitivity test (DTH) to the Leishmania antigen.
When patients were compared with NV we evaluated only the
patients age-matched with the controls (n = 32; 17 men and 15
women). These 32 patients did not show any difference in clinical
and immunological markers when compared to other patients of
the study. For analyses of correlations of hormones with cytokines
we used all patients.
Clinical evaluation for correlations with hormone or cytokine
levels was performed using three parameters: lesion size, time of
disease and dose of antimoniate needed to achieve clinical cure. Le-
sion size was the measurement of the largest diameter of the larg-
est lesion in cm, time of disease was recorded based on patient
information and the dose of antimoniate required was based on
the number of treatment cycles received by the patient.
2.2. Blood collection and processing
Heparinized peripheral blood was collected between 8 a.m. and
11 a.m., transported on ice to the laboratory and the plasma was
stored at 20 C for measurements of hormone levels.
PBMCs were isolated from heparinized venous blood by passage
over a Ficoll Hypaque gradient (Sigma–Aldrich). PBMCs were
washed three times and resuspended at a concentration of
5  106 cells/mL in RPMI 1640 medium (Gibco, NY) supplemented
with 2 mM L-glutamine, penicillin (100 U/mL), streptomycin
(100 lg/mL) (Gibco, NY) and 10% heat inactivated human AB ser-
um (Sigma–Aldrich). Cells were plated in 24-well tissue culture
plates (Costar, Corning Incorporated, NY) at a concentration of
5  106 cells/mL and incubated at 37 C at 5% CO2.Stimulation was performed by adding 10 lg/mL of SLA (soluble
Leishmania antigen). The SLA was prepared as described by Carv-
alho et al. (1985). Brieﬂy, stationary-phase promastigotes of L.
amazonensis (MHOMBR86BA-125) were ultrasonicated and centri-
fuged at 20,000g for 2 h. The supernatant was used at a ﬁnal con-
centration of 10 lg/mL. PBMC culture supernatants were harvested
at 24, 48 and 96 h after in vitro stimulation and maintained at
20 C until use.2.3. Hormone assays
The concentrations of cortisol, DHEA-S, estradiol, prolactin and
testosterone were determined using automated enzyme immuno-
assay-based techniques (ACCESS, Beckman Coulter, Fullerton, CA).
The detection limits for each hormone measured were the follow-
ing: cortisol, 0.4 lg/dL; DHEA-S, 2 lg/dL; estradiol, 2 pg/mL; pro-
lactin, 0.25 ng/mL and testosterone, 0.1 ng/dL.2.4. Cytokine ELISAs
IFN-c, IL-10 and TNF-a (Pharmingen, San Diego, CA) levels were
measured in cell culture supernatants using commercially available
ELISA kits. Culture supernatants were harvested at 96 h for IFN-c,
48 h for IL-10 and 24 h for TNF-a. Assays were performed according
to the manufacturer’s instructions. The detection limits for each
cytokine were as follows: IFN-c, 55 pg/mL; IL-10, 3 pg/mL and
TNF-a, 3 pg/mL.2.5. Statistical analyses
Hormone concentrations in controls and patients were
compared using the Mann–Whitney test. Correlations between
the levels of cytokines and hormones were evaluated with the
Spearman test. All statistical tests were performed using GraphPad
software version 5.0 (GraphPad Software Inc., San Diego, CA, USA).3. Results
3.1. Hormone levels in LCL patients
To determine whether hormone levels were associated with
LCL, we assessed plasma levels of cortisol, estradiol, DHEA-S, pro-
lactin and testosterone in NV and LCL patients with an active cuta-
neous lesion. The clinical proﬁle of the patients analyzed (n = 57) is
shown in Table 1.
LCL patients (n = 32) had lower plasma levels of DHEA-S, prolac-
tin and testosterone than NV (n = 32; Fig. 1C, D and F). No differ-
ence between patients and controls was observed in levels of
cortisol or estradiol (Fig. 1A and B).
Fig. 1. Plasma hormone levels and ratio of DHEA-S to cortisol in patients with LCL and NV. Patients of both sexes (closed triangles; n = 32) were compared with NV of both
sexes (open triangles; n = 32) by the Mann Whitney test. ⁄P < 0.05, ⁄⁄P < 0.01, ⁄⁄⁄P < 0.001.
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clinical markers and cytokine levels
Possible correlations between hormone levels and clinical or
immunological parameters, such as lesion size, healing time, Glu-
cantime dosage and SLA-stimulated IFN-c, IL-10 and TNF-a levels
were analyzed using the Spearman test. We tested the correlation
between each hormone and each clinical parameter or cytokine.
Cortisol showed a positive correlation with healing time and dose
of Glucantime used in the treatment and a negative correlation
with in vitro SLA-stimulated IFN-c levels (Fig. 2A–C). For estradiol,
males were analyzed separately from females because of the con-
siderable difference in the concentration of this hormone betweenFig. 2. Correlationbetweenplasmacortisol levels and clinical and immunologicalmarkers
cure (n = 55; r = 0.279; P = 0.0389) (A) anddose of glucantime (n = 57; r = 0.3231; P = 0.0142the two groups. Plasma levels of estradiol in males correlated
positively with lesion size, whereas in females, a correlation was
observed with total dose of Glucantime used in treatment
(Fig. 3A and B). Prolactin correlated positively with lesion size
and negatively with in vitro IFN-c levels (Fig. 4A and B). Other
correlations tested did not reach statistical signiﬁcance.
3.3. Males and females with LCL have similar changes in hormone
levels
To evaluate whether hormone level changes were similar in
males and females with LCL, each group was tested separately.
Male patients (n = 17) showed a reduction in levels of DHEA-S,in LCLpatients of both sexes. Cortisol had apositive Spearman correlationwith timeof
) (B). Cortisol and IFN-chadanegative correlation (n = 52; r = 0.300; P = 0.0357) (C).
Fig. 3. Correlation between plasma estradiol levels and clinical markers. Estradiol
had a positive Spearman correlation with lesion size (n = 30; r = 0.3754; P = 0.0403)
in males (A) and dose of glucantime (n = 18; r = 0.6559; P = 0.0032) in females (B).
Fig. 4. Correlation between plasma prolactin levels and clinical and immunological
markers. Prolactin had a positive Spearman correlation with lesion size (n = 49;
r = 0.4508; P = 0.0012) (A) and a negative correlation with IFN-c levels (supernatant
of PBMC cultures) (n = 49; r = 0.3764; P = 0.0077) (B).
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and E). Female patients (n = 15) also had lower levels of prolactin
and testosterone compared with controls, but they did show any
difference in concentration of DHEA-S (Figs. 5D, 6D and F).4. Discussion
Immune–endocrine associations have not been sufﬁciently
explored in human leishmaniasis. Herein, we found a reduction
in plasma concentrations of DHEA-S, prolactin and testosterone,
but not of cortisol and estradiol, in LCL patients. Plasma levels of
cortisol, estradiol and prolactin correlated with at least one clinical
marker.
There is only one study addressing an immune–endocrine
imbalance in human leishmaniasis (Gallindo-Sevilla et al., 2007);
this study found lower serum levels of DHEA and cortisol in diffuse
cutaneous leishmaniasis (DCL) patients compared with LCL pa-
tients or healthy volunteers. When DCL patients were excluded
from the study, there was a statistically signiﬁcant reduction of
DHEA in LCL patients compared to age-matched controls. In our
study, a decrease in levels of DHEA-S was observed together with
reductions in levels of prolactin and testosterone. Concentrations
of cortisol and estradiol were similar between LCL patients and
NV. These results are consistent with other results described in
the literature and indicate that infections do not lead to a standard
pattern in neuroendocrine alteration. In some cases, infection in-
duces a reduction and in other cases, infection induces an increase
in the same or different hormones.
The endocrine imbalance observed during chronic infections
could be the result of the activation of various neuroendocrine axes,
such as the HPA axis (hypothalamus–pituitary–adrenal) and the
HPG axis (hypothalamus–pituitary–gonads) by the immune system
(Besedovsky et al., 1986; Webster et al., 2002). Some cytokines,
especially IL-1, IL-6 and TNF-a, can act directly on the central ner-
vous system (CNS), resulting in the activation of neuroendocrine
axes, mainly the HPA axis (Berkenbosch et al., 1987; Holsboer
et al., 1988; Naitoh et al., 1988; Sharp et al., 1989), and hormones
can inﬂuence cytokine production (Besedovsky et al., 1986). More-
over, in some types of infections, the presence of microorganisms
in the glands can affect hormone secretion (Reincke et al., 1998; Cor-
rêa-de-Santana et al., 2006). In LCL, parasites are present almost
exclusively in the skin and draining lymph nodes (de Moura et al.,
2005); therefore, the endocrine imbalance seen in LCL is unlikely
to be caused by the direct presence of the parasite but instead,
may be due to the action of cytokines in the CNS or glands.
Plasma concentrations of somehormones evaluated in this study
correlated with clinical and/or immunological parameters. IFN-c is
the hallmark cytokine of a Th1 immune response and is strongly
linked to protection against leishmaniasis. Cortisol showed a posi-
tive correlation with healing time and dose of Glucantime used in
the treatment and a negative correlation with levels of IFN-c. One
of the major actions of glucocorticoids is to promote a shift from a
Th1 to a Th2 cytokine response (Ramírez et al., 1996; Ashwell
et al., 2000). In LCL, the balanced production of Th1 and Th2 cyto-
kines promotes the healing of lesions because as overproduction
of IFN-c could lead tomore severe tissuedestruction,while high lev-
els of anti-inﬂammatory cytokines could impair parasite clearance
(Boom et al., 1990; Ajdary et al., 2000; Alexander and Bryson,
2005). Studies have reported both the reactivation of cutaneous
and visceral leishmaniasis after glucocorticoid treatment in humans
and mice (Rousseau et al., 1998; Pittalis et al., 2006; Tuon et al.,
2007) and an unusual disseminated mucocutaneous leishmaniasis
resulting from chronic use of glucocorticoids (Motta et al., 2003). A
decreased ratio of DHEA-S to cortisol was observed in LCL patients
in our study, and this also favors the development of a Th2 response.
DHEA-S is a precursor of DHEA and no biological function has been
ascribed to it besides being a precursor of DHEA (Hazeldine et al.,
2010). The long half-life of plasma DHEA-S coupledwith the limited
diurnal variation make DHEA-S a convenient marker for the assess-
ment of adrenal production. DHEA is a potential regulator of
Fig. 5. Plasma hormone levels and ratio of DHEA-S to cortisol in males and females with LCL and NV. Male patients (square) (n = 17) and females patients (circle) (n = 15)
were compared with NV by the Mann Whitney test. ⁄⁄P < 0.01, ⁄⁄⁄P < 0.001.
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(Hazeldine et al., 2010). This hormone can stimulate the IL-2 secre-
tion by T cells and inhibit IL-6 and IL-10 production (Suzuki et al.,
1991; Spencer et al., 1996; Straub et al., 1998). Thus, in LCL, the
HPA axis could be involved in maintenance of a Th2 response and
restriction of the Th1 response.
Plasma levels of estradiol correlated positively with other
important clinical parameters, such as size of the lesion in males
and dose of Glucantime used in treatment in females. Estrogens ex-
hibit several effects on the immune response, some of which could
inﬂuence LCL development. Estrogens can stimulate antibody pro-
duction by B cells as well as production of IL-4 and IL-10 (Kanda
and Tamaki, 1999; Janele et al., 2006; Straub, 2007). In experimen-
tal models of leishmaniasis, antibodies were not protective and
may have enhanced susceptibility to infection (Kima et al., 2000).
IL-4 inhibited IFN-c production and macrophage activation in
experimental models, and IL-10 and other Th2 cytokines led to dis-
ease exacerbation (Boom et al., 1990; Ajdary et al., 2000; Alexander
and Bryson, 2005). Considering such mechanisms, it is possible
that estradiol is involved in lesion development in leishmaniasis.
Prolactin positively correlated with lesion size and negatively
correlated with IFN-c levels. IFN-c and TNF-a can inhibit prolactin
secretion by the anterior pituitary (Walton and Cronin, 1990), and
this could explain the reduction in prolactin levels in individuals
with LCL as these cytokines were elevated in LCL patients.
Although some authors have associated the stimulatory effect of
prolactin with the release of pro-inﬂammatory cytokines, such as
TNF-a, IL-2, IFN-c and IL-12 (Brand et al., 2004; Dimitrov et al.,2004), our results showed a negative correlation between levels
of prolactin and IFN-c. Inhibition of IFN-c production could result
in increased lesion size because this cytokine is necessary for mac-
rophage activation and parasite elimination.
Sexual dimorphism in the immune response has been noted by
many authors (Ansar et al., 1985; Olsen and Kovacs, 1996). Females
exhibit more vigorous humoral responses and a greater tendency
to develop autoimmune disease than males (Butterworth et al.,
1967; Ansar et al., 1985; Klein, 2004). We examined the possibility
that the endocrine changes observed in LCL were detected only in
males or females. Our results indicated that hormonal changes
were similar between the sexes, except for DHEA-S. Levels of
DHEA-S were the same in patients from both sexes, but when pa-
tients were compared with NV, the reduction was more marked in
males than females. This may be due to the fact that healthy male
volunteers had more elevated baseline concentrations of DHEA-S
than healthy female volunteers.
Our results indicate that in LCL, neuroendocrine regulation could
restrict Th1 responses by reducing DHEA-S and prolactin levels and
ratio of DHEA-S to cortisol. Although the Th1 response is necessary
for the elimination of parasites, the overproduction of IFN-c and
TNF-awouldbeharmful to the host, as high levels of these cytokines
could increase damage to tissue. The decrease in plasma testoster-
one levels detected in LCL patients could also contribute to host
defense mechanisms as this hormone is associated with an
increased susceptibility to many parasitic infections, including
experimental leishmaniasis (Mock and Nacy, 1988; Klein, 2004).
Testosterone exhibits several immunosuppressive effects, such as
Fig. 6. Plasma hormone levels in males and females with LCL and NV. Male patients (square) (n = 17) and female patients (circle) (n = 15) were compared with NV by the
Mann Whitney test. ⁄P < 0.05, ⁄⁄⁄P < 0.001, ⁄⁄⁄⁄P < 0.0001.
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(Zhang et al., 2001; Klein, 2004). Although the estradiol levels in
LCLpatientswere similar to those in theNV, there is apossibility that
the reduction in testosterone levels could result in its conversion to
estradiol because inﬂammatory cytokines have been found to stim-
ulate aromatase activity (Cutolo et al., 2004). In conclusion our
results indicate thatpatientswith LCL canexhibit an immune–endo-
crine imbalance with reduction of plasma levels of DHEA-S, prolac-
tin and testosterone. The endocrine–immune interactions can play
an important role in LCL as the levels of some hormones correlate
with cytokine levels and clinical markers. The present study
provides new insights into the regulation of the immune response
in leishmaniasis. The neuroimmunomodulation observed in LCL
patients appears to be beneﬁcial to the host and contributes to the
healing of lesions. Perhaps more aggressive forms of leishmaniasis
may be the result of changes in neuroendocrine regulation.
Knowledge of the endocrine mechanisms involved in regulating
the immune response in LCL could be important for development
of pharmacological alternatives for treatment of this disease.Acknowledgments
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